What is the recommended treatment for sun allergy (photosensitivity)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Sun Allergy (Photosensitivity)

The treatment approach depends on the specific type of sun allergy, but for the most common form—polymorphic light eruption (PLE)—start with strict photoprotection using high SPF sunscreens and UV avoidance, escalating to prophylactic narrowband UVB or PUVA phototherapy in early spring if initial measures fail. 1

Initial Management: All Sun Allergies

Photoprotection and Avoidance

  • Apply high SPF broad-spectrum sunscreens to all exposed skin and strictly limit UV radiation exposure 2
  • Identify and eliminate any potential photosensitizing medications or chemicals that may be triggering the reaction 3, 2
  • For photocontact dermatitis specifically, perform patch and photopatch testing to identify the culprit allergen (commonly sunscreen ingredients like oxybenzone or topical NSAIDs), then avoid that specific chemical 4, 5

Condition-Specific Treatment Algorithms

Polymorphic Light Eruption (PLE)

First-line approach:

  • High SPF sunscreens combined with UV avoidance 2
  • Potent topical corticosteroids to manage acute flares 1

Second-line for inadequate response:

  • Prophylactic phototherapy (narrowband UVB or PUVA) administered twice weekly for 12-20 treatments in early spring before peak sun exposure season 1
  • PUVA should be considered if UVB has failed or previously triggered eruptions 1
  • Important timing consideration: Administer phototherapy early enough in spring that protection extends through summer, but not so early that the photoprotective effect wanes by mid-summer 1

Managing provocation during phototherapy:

  • Expect provocation in 12-50% of treatment courses 1
  • Treat provocation episodes with potent topical steroids, lower dose increments, and omit 1-2 treatments if severe 1
  • Consider prophylactic oral prednisolone 40-50 mg for the first 2 weeks of phototherapy to prevent provocation 1
  • Manage pruritus with oral corticosteroids if needed 1

Post-treatment maintenance:

  • Continue cautious natural sunlight exposure (2 hours weekly minimum) to maintain photoprotection through summer 1

Solar Urticaria (SU)

First-line treatment:

  • High-dose H1 antihistamines (desloratadine, fexofenadine, cetirizine) are the standard therapy 1, 6
  • Add leukotriene receptor antagonist (montelukast) in combination with antihistamines, tailored to disease severity 6

Second-line for refractory cases:

  • Determine the action spectrum and minimal urticaria dose (MUD) through specialized monochromator phototesting before initiating phototherapy 1
  • Narrowband UVB has been reported effective and may be safer than PUVA 1
  • PUVA can be considered only after full assessment in a specialized photodermatology unit, with initiating dose lower than the MUD 1
  • Critical safety warning: Phototherapy in solar urticaria carries risk of provocation, syncope, and anaphylaxis—requires close supervision 1

Chronic Actinic Dermatitis (CAD)

  • PUVA phototherapy must be undertaken under close supervision with cover of topical or systemic corticosteroids 1
  • Maintenance treatment may be required 1
  • Consider systemic immunosuppressants (cyclosporine, azathioprine) for severe cases 2
  • Balance therapeutic benefit against long-term skin cancer risk—annual repeated phototherapy courses are not routinely recommended 1

Actinic Prurigo

  • Narrowband UVB is safer than PUVA (particularly in children) and should be considered first-line phototherapy 1
  • Low-dose thalidomide may be necessary for refractory cases 2
  • High SPF sunscreens and UV restriction remain foundational 2

Critical Caveats and Pitfalls

Phototherapy timing and carcinogenesis:

  • The photoprotective effect from phototherapy diminishes several weeks post-treatment 1
  • Weigh the long-term skin cancer risk against therapeutic benefit when considering repeated annual courses 1

Drug-induced photosensitivity:

  • Always review medications for photosensitizing agents (common culprits include thiazides, fluoroquinolones, NSAIDs, tetracyclines) 3
  • Cessation of the culprit drug is essential; if the drug is indispensable, maximize photoprotection 3

Sunscreen allergens:

  • Oxybenzone (benzophenone-3) is the most common UV filter causing allergic and photoallergic contact dermatitis 5
  • Switch to mineral-only sunscreens (zinc oxide, titanium dioxide) if organic UV filter allergy is suspected—these have no reports of allergic or photoallergic reactions 5

Pregnancy considerations:

  • Avoid PUVA therapy during pregnancy and discontinue if pregnancy occurs 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.